PHI with Hemorrhoid sclerosis
How does this condition affect your private health insurance?
Hämorrhoidenverödung, also known as hemorrhoid sclerotherapy, is a common minimally invasive procedure for treating internal hemorrhoids, typically grades I and II. It involves injecting a chemical solution (sclerosant) near the hemorrhoid. This solution irritates the tissue, causing it to scar and shrink, which reduces bleeding, discomfort, and prolapse. The procedure is performed in an outpatient setting, often without anesthesia, and usually takes only a few minutes. It aims to alleviate symptoms effectively, allowing patients to quickly return to their daily routines. While highly effective for symptom relief, multiple sessions might be needed, and recurrence is possible over time.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Hemorrhoid symptoms requiring sclerotherapy can range from a few days of acute discomfort and bleeding to several weeks or months of intermittent or persistent symptoms before seeking treatment.
Duration of Illness (Lifetime)
Hemorrhoidal disease can be a chronic or recurrent condition over a lifetime, often managed with lifestyle changes, medications, and sometimes repeated procedures like sclerotherapy.
Cost of Treatment (Initial)
The cost for a single sclerotherapy session typically ranges from 100 to 400 USD, often covered by health insurance in many regions.
Cost of Treatment (Lifetime)
Over a lifetime, costs may vary significantly from a few hundred dollars for isolated treatments to several thousands if multiple sessions, different procedures, or surgical interventions become necessary due to recurrence or progression.
Mortality Rate
Extremely low, practically negligible (less than 0.001%) when performed correctly by a qualified medical professional, primarily associated with extremely rare systemic complications.
Risk of Secondary Damages
Low (5-10%), usually mild and temporary, including local pain, bleeding, infection, allergic reaction to the sclerosant, or temporary worsening of symptoms. More severe complications are rare.
Probability of Full Recovery
High for symptom resolution (70-90%) after one or more sessions, especially for early-stage hemorrhoids. However, complete and permanent eradication of the underlying condition with no future recurrences is lower (around 50-60%) as predisposing factors may persist.
Underlying Disease Risk
Very low (less than 1-2%). Hemorrhoids are typically a standalone condition. However, persistent rectal bleeding always warrants investigation to rule out more serious underlying conditions like inflammatory bowel disease or colorectal cancer, although these are rarely directly 'underlying' causes of the hemorrhoid itself but rather co-existing conditions.